Navigation Links
BioMS Medical Announces 2008 Year End Results
Date:3/17/2009

,921 Amortization of licensing costs 11,755 1,472 1,472 Amortization of property and equipment 517 125 134 Loss on disposal of property and equipment 11 11 - ------------ -------- -------- (118,881) 3,343 (43,681) Net change in non-cash working capital items Goods and services tax recoverable (299) 185 (28) Prepaid and other current assets (2,548) 734 (571) Advanced clinical trial costs (790) 1,186 (1,976) Accounts payable and accrued liabilities 9,151 (601) 933 Deferred revenue 45,605 45,605 - ------------ -------- -------- (67,762) 50,452 (45,323) ------------ -------- -------- Investing activities Purchase of property and equipment (1,045) (323) (109) Net (purchase of) proceeds from short-term investments (2,614) (86) 3,149 Licensing costs (6,467) - - ------------ -------- -------- (10,126) (409) 3,040 ------------ -------- -------- Financing activities Proceeds from issuance of share capital 178,729 91 44,512 Repurchase of share capital (3,552) (1,434) (36) Share issue costs (12,312) - (3,332)
'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMS Medical warrant extension
2. BioMS Medical to present at BIO CEO and Investor Conference
3. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
4. BioMS Medical recognized at Scrip Awards 2008
5. BioMS Medical Announces Third Quarter 2008 Results
6. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. BioMS Medical to present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... and NEW YORK , Dec. 24, ... a biopharmaceutical company advancing patient care in critical areas, ... 3,500,000 shares of common stock, and warrants to purchase ... at an offering price of $4.00 per share and ... exercise price of $5.00, are exercisable immediately, and expire ...
(Date:12/24/2014)... December 23, 2014 Earlier this year ... L. Sherley, director of the Adult Stem Cell Technology ... often overlooked and under appreciated unique property of adult ... Distributed Stem Cells: Misunderstood in the Past, Important for ... congress participants. He gave the address at the ...
(Date:12/24/2014)... 23, 2014 Nashville Fertility Center announced ... treasurer for the American Society for Reproductive Medicine (ASRM), ... research in reproductive medicine. In his new role ... the executive board and will have a voice in ... has actively supported ASRM since 1984 when he joined ...
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3
... Dec. 22, 2010 Neogen Corporation (Nasdaq: ... 2nd Q Results WebcastWhen: , Tuesday, January 4, 2011 ... over the Internet -- Simply log on to the ... Maynard of Neogen Corporation, +1-800-234-5333.If you are unable to ...
... 21, 2010) -- A researcher known widely for ... use of minimally toxic, environmentally friendly chemicals will ... Dr. Paul Anastas, science advisor to the U.S. ... the EPA,s Office of Research and Development (ORD), ...
... YORK, Dec. 21, 2010 Reportlinker.com announces that ... its catalogue: Nanobiotechnologies- applications, markets ... SummaryNanotechnology is the creation and ... control of matter on the nanometer-length scale (a ...
Cached Biology Technology:Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations 2Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations 3Reportlinker Adds Nanobiotechnologies- applications, markets and companies 2Reportlinker Adds Nanobiotechnologies- applications, markets and companies 3Reportlinker Adds Nanobiotechnologies- applications, markets and companies 4Reportlinker Adds Nanobiotechnologies- applications, markets and companies 5Reportlinker Adds Nanobiotechnologies- applications, markets and companies 6Reportlinker Adds Nanobiotechnologies- applications, markets and companies 7Reportlinker Adds Nanobiotechnologies- applications, markets and companies 8Reportlinker Adds Nanobiotechnologies- applications, markets and companies 9Reportlinker Adds Nanobiotechnologies- applications, markets and companies 10Reportlinker Adds Nanobiotechnologies- applications, markets and companies 11Reportlinker Adds Nanobiotechnologies- applications, markets and companies 12Reportlinker Adds Nanobiotechnologies- applications, markets and companies 13Reportlinker Adds Nanobiotechnologies- applications, markets and companies 14Reportlinker Adds Nanobiotechnologies- applications, markets and companies 15Reportlinker Adds Nanobiotechnologies- applications, markets and companies 16Reportlinker Adds Nanobiotechnologies- applications, markets and companies 17Reportlinker Adds Nanobiotechnologies- applications, markets and companies 18Reportlinker Adds Nanobiotechnologies- applications, markets and companies 19Reportlinker Adds Nanobiotechnologies- applications, markets and companies 20Reportlinker Adds Nanobiotechnologies- applications, markets and companies 21
(Date:12/17/2014)...  HITLAB SM announced today its completion ... confirm its adherence to current U.S. Food and ... to conduct regulated smart device and smart phone ... safety and research quality. "HITLAB is ... delivery with innovative technology," said Laura Pugliese ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... to their offering. One major ... technology. With continuous advances in technology, it is ... standard that meets the needs and expectations of ...
(Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Curcumin, the major component in the spice turmeric, ... suppression of head and neck cancer cell growth, researchers ... naturally occurring spice widely used in South Asian and ... have medicinal properties, attributed to its anti-inflammatory effects. Previous ...
... cancer might soon be increased with a new vitamin E ... of Technology (QUT) prostate cancer researchers are leading the fight ... Dr Patrick Ling, whose research will be a centrepiece ... it opens in Brisbane, is leading a team of researchers ...
... Junction, NJ (October 19, 2010) Patients undergoing ... Inc.,s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a ... infection rate of 0.48% in the first 1.9 ... published results of TYRX,s COMMAND Clinical Study. There ...
Cached Biology News:Major component in turmeric enhance effect of chemotherapy drug in head and neck cancer 2Major component in turmeric enhance effect of chemotherapy drug in head and neck cancer 3Vitamin E in front line of prostate cancer fight 2Vitamin E in front line of prostate cancer fight 3TYRX AIGISRx antibacterial envelope shows low infection rate, high CIED procedure success 2
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
... been developed specifically for the stabilization ... microwell plates/strips. Coating Stabilizer maintains ... antibody or protein antigen portion of ... is filtered at 0.2 microns., ,Contents: ...
... Block is an anodized aluminum, solvent-resistant block ... to provide efficient thermal transfer to samples ... of the HT96 Isothermal Block replaces Cat. ... design allowing for compatibility with robotic applications. ...
Biology Products: